Approval of Modification of draft Scheme of Amalgamation submitted on November 12, 2025 between Hatri Pharma Private Limited (Transferor Company) and Venmax Drugs and Pharmaceuticals Limited (Transferee Company)
Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 27 2026
Filed with BSE · · 33 pages · English
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 26 2026
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 23 2026
- Announcement under Regulation 30 (LODR)-Allotment
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 09 2026
Later from Venmax Drugs & Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Change in Management
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 30 2026
- Regulation 31(4) - SAST Disclosure
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 06 2026
- Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals